Vitamins is expected to demonstrate moderate constant value growth over the forecast period. New healthy habits and a stronger focus on preventative health through supplementation will support sales, with a focus on supporting the immune system.
Single vitamins will continue to enjoy moderate growth over the forecast period, even after the dynamic performance in recent years. Vitamins B and D will lead this category, which are both expected to post above average performance during the forecast period.
Due to economic uncertainty, private label is expected to gain retail value share during the forecast period. Private label ranges from major pharmacy chains, such as Livsane from Benu, are expanding their product portfolios, with greater investment in packaging, paediatric formats and marketing overall.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Vitamins industry in Latvia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Vitamins industry in Latvia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Vitamins
This report originates from Passport, our Vitamins research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!